The challenge
Annex 1 of the EU GMP guidelines sets more stringent requirements for the manufacture of sterile medicinal products, with contamination control prevention being one of them. This new set of requirements includes robust sterility control, precise validation, complex facility design and extensive automation. These challenges make the process and production line set up highly capital and knowledge extensive. Particularly for organizations transitioning from lower grade cleanroom operations.
This is where specialist and experienced pharma service providers like Ensera can provide valuable support, supplying pre-sterilized and packed components in a ready-to-use format.